Results 11 to 20 of about 32,245 (181)

Quantification of Pneumocystis jirovecii: Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes

open access: yesJournal of Fungi, 2019
Diagnosis of Pneumocystis jirovecii pneumonia relies on nucleic acid quantification in respiratory samples. Lack of standardization among molecular assays results in significant differences among assays/centers.
Sarah Dellière   +5 more
doaj   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Pneumocystis jirovecii

open access: yesTrends in Microbiology, 2020
International ...
Nevez, Gilles   +2 more
openaire   +4 more sources

Lung Injury in COVID-19 and Pneumocystis Pneumonia. Similarities and Differences

open access: yesТуберкулез и болезни лёгких, 2022
In the regions with the high prevalence of HIV infection, it is necessary to perform differential diagnosis of lung injury caused by COVID-19 and pneumocystis pneumonia.The main complaints in COVID-19 and pneumocystis pneumonia are similar and include ...
E. A. Borodulina   +2 more
doaj   +1 more source

Pneumocystis Pneumonia

open access: yesJournal of the Formosan Medical Association, 2008
Pneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has recently been reclassified as a fungus because its cell wall composition and nucleotide sequences are more similar to those of fungi. PcP occurs only in immunocompromised individuals such as those with AIDS. Despite the use of highly active antiretroviral therapy, PcP
Jang-Jih Lu, Chao-Hung Lee
openaire   +4 more sources

Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Infection with the opportunistic fungal pathogen, Pneumocystis jirovecii causes life-threatening pneumonia in immunocompromised individuals. In addition to HIV-1 infected patients, individuals at risk of Pneumocystis infection include those receiving ...
Viviana Cobos Jiménez   +3 more
doaj   +1 more source

Pneumocystis jirovecii infection [PDF]

open access: yesThorax, 2004
A review of Pneumocystis and the rationale for renaming it The organism Pneumocystis causes severe pneumonia in individuals with immune systems impaired by HIV, transplantation, malignancy, connective tissue disease, and the treatment thereof. In HIV infected patients it remains a major pathogen in those who are unaware of their HIV serostatus, or who
R, Miller, L, Huang
openaire   +2 more sources

The role of opportunistic pathogens as etiological agents of intrauterine infections

open access: yesДетские инфекции (Москва), 2019
The study showed a high prevalence of markers of herpesvirus infections among mothers — from 71% to 98% of HSV, EBV and CMV infections and from 29% to 58% of HHV-6 infection.
V. V. Kosenchuk   +8 more
doaj   +1 more source

Predicting Species Boundaries and Assessing Undescribed Diversity in Pneumocystis, an Obligate Lung Symbiont

open access: yesJournal of Fungi, 2022
Far more biodiversity exists in Fungi than has been described, or could be described in several lifetimes, given current rates of species discovery. Although this problem is widespread taxonomically, our knowledge of animal-associated fungi is especially
Spenser J. Babb-Biernacki   +2 more
doaj   +1 more source

Peran Steroid pada Pneumocystis Pneumonia Ditinjau Berdasarkan Imunopatogenesis [Immunopathogenesis of Steroid in Pneumocystis Pneumonia]

open access: yesJurnal Respirasi, 2019
Pneumocystis Pneumonia (PCP) is a potentially life-threatening infection that can occur in individuals who are immunocompromised. In PCP steroid use is still recommended especially in patients with moderate and severe severity.
Resti Yudhawati, Whendy Wijaksono
doaj   +1 more source

Home - About - Disclaimer - Privacy